Environmental risk factors of young onset Parkinson's disease: a case-control study

https://doi.org/10.1016/S0303-8467(02)00027-6Get rights and content

Abstract

While the cause of Parkinson's disease (PD) remains unknown, recent evidence suggests certain environmental factors, such as well water drinking, herbicides and pesticides exposure, and neurotoxins, may trigger the chain of oxidative reactions culminating in the death of dopaminergic neurons in substantia nigra to cause parkinsonism. Most studies to date focused on PD with old age onset. However, there is a peculiar group of parkinsonian patients, the young onset Parkinson's disease (YOPD), in whom the age of onset is before 40. It is intriguing to know whether earlier exposure to the putative neurotoxin(s) may contribute to the earlier onset. We therefore conducted this case-control study in which 60 PD patients, 30 YOPD patients and the same number of age- and sex-matched young controls were included. Using logistic regression, we found well water drinking and head injury were risk factors for the development of YOPD. When YOPD patients were compared with PD, we found head injury and exercise were the significant predictors. Keeping all other variables constant, head injury was a risk factor and exercise appeared to be a protective factor. We conclude early exposure to well water drinking and head trauma may trigger and expedite the appearance of parkinsonian features, but such acceleration may be prevented through regular exercise.

Introduction

Since the description in 1817, the etiology of Parkinson's Disease (PD) remains unknown. No single factor has been definitely attributed to the cause of PD. Nevertheless, cumulative pieces of evidence have implicated rural living [9], [12], [22], [24], [26], [28], [32], [38] well water drinking [12], [22], [24], [32], [38] herbicides and pesticides exposure [6], [9], [12], [14], [22], [26], and proximity to industry [30], [31] as risk factors for the disease. The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism further suggests a similar neurotoxin might cause PD [2], [4]. These findings lend credence to the notion that certain sorts of environmental agents can trigger the chain of reactions resulting in the death of dopaminergic neurons in substantia nigra to cause parkinsonism.

As PD incidence varies greatly with age, which begins to rise after the age of 50 and reaches the maximum at about 75, most epidemiological surveys focused on this age range [9], [26]. However, there is a peculiar group of parkinsonian patients, the Young Onset Parkinson's Disease (YOPD), in whom the age of onset is before 40. Some of them even presented the first symptoms in their teens. These YOPD patients constitute about 3–10% of total patients with PD on hospital-based data [7], [23], [34], [35], [39]. From pathological and clinical view points, parkinsonism with age of onset before and after 40 years are probably the same [8], [16]. Thus, it is intriguing to know whether risk factors found in classical PD might also be implicated in the occurrence of YOPD. With all other considerations being equal, it is wondered how exposure to similar environment risk factors could cause such a great discrepancy in the disease onset age. Would it presumably indicate an earlier or more intensive exposure to the causative agents in YOPD as compared with typical late onset cases? The main objective of this study is to investigate the risk factors implicated in the occurrence of YOPD. We are also keen to examine the differences, if any, in these factors between YOPD and PD patients.

Section snippets

Subjects and methods

To meet our research objectives, the subjects were divided into three groups, namely YOPD, YOPD controls and PD. In order to be included in our study as a patient subject, at least two of the three cardinal parkinsonian features, including akinesia, rigidity, and tremor, must be present [23], [33], [35]. Known causes for secondary parkinsonism, such as Wilson's disease, intoxication (CO, CS2, Mn), Segawa's disease, encephalitis, pallidopyramidal disease, or Hallervorden–Spatz disease, were

Results

Fifty two patients were registered as YOPD in our Movement Disorder data bank. Thirty nine of them were available to be interviewed and examined. Nine patients, from five families, had a positive family history of parkinsonism and were excluded from the current study. Among these nine patients, two from the same family were found to have homozygous deletional mutation of exon three of the parkin gene [15]. A total of 30 (F:M=10:20) YOPD patients, an equal number of YOPD controls, and 60

Discussion

The relationship between environmental factors and Parkinson's disease is always an intriguing issue and remains elusive. In the current study, we focus our attention on the causal linkage between the environmental factors and YOPD. In a preliminary univariate analysis, we noted YOPD patients differ from their controls in daily cigarettes smoked number and exercise duration. Since more than 30 comparisons were made using ANOVA, an application of the Bonferroni adjustment, in which the overall

Acknowledgements

The study was supported by a grant from the National Science Council (NSC 83-0412-B182A-009).

References (39)

  • G.C. Davis et al.

    Chronic parkinsonism secondary to intravenous injection of meperidine analogues

    Psychiatry Res.

    (1979)
  • A. Priyadarshi et al.

    Environmental risk factors and Parkinson's disease: a metaanalysis

    Environ. Res.

    (2001)
  • Y. Ben-Shlomo

    How far are we in understanding the cause of Parkinson's disease

    J. Neurol. Neurosurg. Psychiatry

    (1996)
  • R.S. Burns et al.

    The clinical syndrome of striatal dopamine deficiency

    New Eng. J. Med.

    (1985)
  • P.B.S. Clarke et al.

    Electrophysiological actions of nicotine on substantia nigral single units

    Br. J. Pharmcol.

    (1985)
  • R. Doll et al.

    Mortality in relation to smoking: 40 years’ observations on male British doctors

    Br. Med. J.

    (1994)
  • T. Endo et al.

    Effects of a paraquat-containing herbicide, gramoxon, on the central monoamines and acetylcholine in mice

    Res. Commun. Psychol. Psychiatr. Behav.

    (1988)
  • O.S. Gershanik et al.

    Juvenile onset Parkinson's disease

  • W.R.G. Gibb et al.

    A comparison of clinical and pathological features of young- and old- onset Parkinson's disease

    Neurology

    (1988)
  • S.C. Ho et al.

    Epidemiologic study of Parkinson's disease in Hong Kong

    Neurology

    (1989)
  • J.P. Hubble et al.

    Risk factors for Parkinson's disease

    Neurology

    (1993)
  • F.J. Jimenez-Jimenez et al.

    Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study

    Mov. Disord.

    (1992)
  • W. Koller et al.

    Environmental risk factors in Parkinson's disease

    Neurology

    (1990)
  • J. Le Houezec et al.

    Basic and clinical psychopharmacology of nicotine

    Clin. Chest Med.

    (1991)
  • R. Lewin

    Parkinson's disease: an environmental cause?

    Science

    (1985)
  • C.S. Lu et al.

    Clinical and genetic studies on familial parkinsonism: the first report on a parkin gene mutation in a Taiwanese family

    Mov. Disord.

    (2001)
  • S.M. Ludin et al.

    Is Parkinson's disease of early onset a separate disease entity?

    J. Neurol.

    (1989)
  • H. Matsumine et al.

    Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27

    Am. J. Hum. Genet.

    (1997)
  • H. Matsumine et al.

    Early onset parkinsonism with diurnal fluctuation maps to a locus for juvenile parkinsonism

    Neurology

    (1998)
  • Cited by (69)

    • Blueberry juice augments exercise-induced neuroprotection in a Parkinson's disease model through modulation of GDNF levels

      2022, IBRO Neuroscience Reports
      Citation Excerpt :

      Our results suggest a similar potentiation of pro-survival signaling may be involved in the greater protection observed with exercise and BBJ intake in our PD model. Epidemiological data suggests that exercise or diets rich in polyphenols reduce the risk of developing PD (Tsai et al., 2002; Chen et al., 2005; Gao et al., 2007; Gao et al., 2012) and may be an adjunct symptomatic treatment for PD patients. Our results raise the possibility that combined use of exercise and consumption of polyphenol-rich foods may impart neuroprotective benefits greater than either of these treatments alone.

    • Escitalopram-induced Parkinsonism

      2014, General Hospital Psychiatry
    View all citing articles on Scopus
    View full text